original ) (raw )Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and ratio measurements and their relationship with an index of clinical activity in the management of patients with acromegaly
R. García-mayor
Metabolism, 1997
View PDFchevron_right
Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly
Enrica Ciccarelli
Acta Endocrinologica, 1989
View PDFchevron_right
Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study
Naresh Sachdeva
The Journal of the Association of Physicians of India, 2014
View PDFchevron_right
An acromegalic patient with low Insulin-Like Growth Factor-1 levels: it may not be found to be elevated during diagnosis of acromegaly each time
Mithat Bahceci
2015
View PDFchevron_right
Insulin Like Growth Factor Binding Protein 7 as a Novel Diagnostic Marker in Sera of Iraqi Patients with Acromegaly
esam noori
Baghdad Science Journal, 2023
View PDFchevron_right
Relationship between Disease-Related Morbidity and Biochemical Markers of Activity in Patients with Acromegaly
Kalmon Post
The Journal of Clinical Endocrinology & Metabolism, 2005
View PDFchevron_right
Plasma Insulin-Like Growth Factor-I/Somatomedin-C in Acromegaly: Correlation With the Degree of Growth Hormone Hypersecretion*
Ariel Barkan
The Journal of Clinical Endocrinology & Metabolism, 1988
View PDFchevron_right
Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly
Stephen Shalet
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2001
View PDFchevron_right
Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly
Mariana Purice
Pituitary, 2012
View PDFchevron_right
Biochemical markers of acromegaly: GH vs. IGF-I
Ariel Barkan
Growth Hormone & IGF Research, 2004
View PDFchevron_right
Inverse correlation between insulin‐like growth factor binding protein‐I and insulin in patients with acromegaly during treatment with the somatostatin analogue octreotide
jyoti bala
Clinical Endocrinology, 1994
View PDFchevron_right
Inter-relations between growth hormone, insulin, insulin-like growth factor-l (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly
Jeff Holly
Clinical Endocrinology, 1991
View PDFchevron_right
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system
Diego Barreca
Clinical Endocrinology, 2004
View PDFchevron_right
IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition
Jean Claude Patilla Fernandez
Pituitary, 2015
View PDFchevron_right
Acromegaly Associated with Type 2 Diabetes Showing Normal IGF-1 Levels under Poorly Controlled Glycemia
Bong-yun Cha
Endocrine Journal, 2007
View PDFchevron_right
The Relationship between 24-Hour Growth Hormone Secretion and Insulin-Like Growth Factor I in Patients with Successfully Treated Acromegaly: Impact of Surgery or Radiotherapy
Stephen Shalet
The Journal of Clinical Endocrinology & Metabolism, 2001
View PDFchevron_right
Filter paper collection of plasma for IGF-I test in patients with acromegaly
Pai Kao
Annals of clinical and laboratory science, 2002
View PDFchevron_right
Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments
Ignacio Bernabeu , Ana Ramos-levi
European journal of endocrinology / European Federation of Endocrine Societies, 2015
View PDFchevron_right
Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements
Ferdinand Roelfsema
View PDFchevron_right
How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
Alberto Pereira
Pituitary, 2018
View PDFchevron_right
Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and ratio measurements and their relationship with an index of …
R. García-mayor
Metabolism- …, 1997
View PDFchevron_right
Measurement of salivary insulin-like growth factor-I in acromegaly: comparison with serum insulin-like growth factor-I and growth hormone concentrations
M. Korsić
Clinical Chemistry …, 1994
View PDFchevron_right
Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report
Chamara Dalugama
Journal of Medical Case Reports, 2015
View PDFchevron_right
Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment
Federico Gatto
The Journal of Clinical Endocrinology & Metabolism
View PDFchevron_right
Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population
Antonio Picó
Clinical Endocrinology, 2008
View PDFchevron_right
Remission criteria for the follow-up of patients with acromegaly
G. Erdoğan , Sevim Gullu
European Journal of Endocrinology, 2004
View PDFchevron_right
Decreased Quality of Life in Patients with Acromegaly Despite Long-Term Cure of Growth Hormone Excess
Ferdinand Roelfsema
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR®
Giselle Taboada
Growth Hormone & IGF Research, 2008
View PDFchevron_right
Predictors of morbidity and mortality in acromegaly: an Italian survey
paola berchialla
European journal of endocrinology / European Federation of Endocrine Societies, 2012
View PDFchevron_right
Predictors of morbidity and mortality in acromegaly: A multicentric Italian study
Maura Arosio
Annales d'Endocrinologie, 2012
View PDFchevron_right